Quest Diagnostics Total Long-Term Assets 2010-2024 | DGX

Quest Diagnostics total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
  • Quest Diagnostics total long-term assets for the quarter ending September 30, 2024 were $13.472B, a 15.47% increase year-over-year.
  • Quest Diagnostics total long-term assets for 2023 were $11.65B, a 6.5% increase from 2022.
  • Quest Diagnostics total long-term assets for 2022 were $10.939B, a 0.63% increase from 2021.
  • Quest Diagnostics total long-term assets for 2021 were $10.87B, a 0.89% decline from 2020.
Quest Diagnostics Annual Total Long-Term Assets
(Millions of US $)
2023 $11,650
2022 $10,939
2021 $10,870
2020 $10,968
2019 $10,353
2018 $9,613
2017 $9,197
2016 $8,569
2015 $8,461
2014 $8,254
2013 $7,565
2012 $7,723
2011 $7,912
2010 $6,922
2009 $6,884
Quest Diagnostics Quarterly Total Long-Term Assets
(Millions of US $)
2024-09-30 $13,472
2024-06-30 $11,864
2024-03-31 $11,726
2023-12-31 $11,650
2023-09-30 $11,667
2023-06-30 $11,692
2023-03-31 $10,980
2022-12-31 $10,939
2022-09-30 $10,889
2022-06-30 $10,886
2022-03-31 $10,967
2021-12-31 $10,870
2021-09-30 $10,718
2021-06-30 $10,715
2021-03-31 $10,932
2020-12-31 $10,968
2020-09-30 $10,795
2020-06-30 $10,610
2020-03-31 $10,489
2019-12-31 $10,353
2019-09-30 $10,240
2019-06-30 $10,194
2019-03-31 $10,159
2018-12-31 $9,613
2018-09-30 $9,383
2018-06-30 $9,332
2018-03-31 $9,324
2017-12-31 $9,197
2017-09-30 $8,895
2017-06-30 $8,671
2017-03-31 $8,551
2016-12-31 $8,569
2016-09-30 $8,531
2016-06-30 $8,599
2016-03-31 $8,604
2015-12-31 $8,461
2015-09-30 $8,426
2015-06-30 $8,190
2015-03-31 $8,238
2014-12-31 $8,254
2014-09-30 $8,238
2014-06-30 $8,252
2014-03-31 $8,062
2013-12-31 $7,565
2013-09-30 $7,502
2013-06-30 $7,566
2013-03-31 $7,849
2012-12-31 $7,723
2012-09-30 $7,846
2012-06-30 $7,916
2012-03-31 $7,933
2011-12-31 $7,912
2011-09-30 $7,930
2011-06-30 $7,953
2011-03-31 $6,925
2010-12-31 $6,922
2010-09-30 $6,907
2010-06-30 $6,850
2010-03-31 $6,871
2009-12-31 $6,884
2009-09-30 $6,895
2009-06-30 $6,872
2009-03-31 $6,862
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $18.293B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.347B 11.70
DaVita (DVA) United States $13.459B 17.41
Encompass Health (EHC) United States $10.015B 23.61
Chemed (CHE) United States $8.477B 26.05
Elanco Animal Health (ELAN) United States $6.624B 15.77
RadNet (RDNT) United States $6.018B 133.28
Option Care Health (OPCH) United States $3.827B 18.14
Amedisys (AMED) United States $2.953B 21.02
LifeStance Health (LFST) United States $2.797B 0.00
Astrana Health (ASTH) United States $2.369B 32.39
Addus HomeCare (ADUS) United States $2.191B 25.71
U.S Physical Therapy (USPH) United States $1.463B 38.47
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.048B 42.36
Atai Life Sciences (ATAI) Germany $0.255B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.008B 0.00
ATI Physical Therapy (ATIP) United States $0.007B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00